Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

EU regulator recommends clearing Takeda's dengue vaccine

Por: ABC News Health October 14, 2022

thumbnail

LONDON -- The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.The EU regulator said in a statement the vaccine should be cleared for anyone aged four and over, to prevent the four types of dengue. The viral disease causes more than 390 million infections globally every year,... + full article



Similar News

EU regulator recommends clearing Takeda's dengue vaccine

Associated Press USA Health October 15, 2022

thumbnailLONDON (AP) — The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.The EU regulator said in a statement... + más

EU regulator recommends clearing Takeda's dengue vaccine | ABC News

EU regulator recommends clearing Takeda's dengue vaccine | WPLG Local 10


Takeda: CHMP Recommends Approval Of Dengue Vaccine Candidate, TAK-003

RTTNews USA Health October 14, 2022

thumbnailTakeda () announced the CHMP of the European Medicines Agency recommended the approval of the company's dengue vaccine candidate, TAK-003, for the prevention of dengue disease caused by any serotype in individuals four years of age and older in Europe and in dengue-endemic... + más

EU regulator recommends clearing Takeda's dengue vaccine | ABC News

EU regulator recommends clearing Takeda's dengue vaccine | WPLG Local 10


EU regulator recommends clearing Takeda's dengue vaccine

WPLG Local 10 USA Health October 14, 2022

thumbnailLONDON – The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.The EU regulator said in a statement the... + más

EU regulator recommends clearing Takeda's dengue vaccine | ABC News

EU regulator recommends clearing Takeda's dengue vaccine | Associated Press


‘The Night Eaters’ Is A Slow-Burning Graphic Horror Classic

Forbes USA Business October 11, 2022

thumbnailThe Night Eaters by Marjorie Liu and Sana Takeda, published October 11, 2022 by Abrams ComicArtsArt by Sana Takeda Writer Marjorie Liu and artist Sana Takeda are more than tellers of stories: they are makers of worlds. Their New York Times best-selling, multiple award-winning... + más

‘American Horror Story’ season 11 title, release date and cast announced | Fox News

The 16 best horror movies to watch on Hulu, from 'Hellraiser' to 'Little Monsters' | Business Insider


A single dose of monkeypox vaccine provides some protection against infection, CDC says

CNBC USA Health September 28, 2022

thumbnailLos Angeles, CA - August 10: Luis Garcia, a registered nurse, prepares Monkeypox virus vaccine at St.John's Well Child & Family Center on Wednesday, Aug. 10, 2022 in Los Angeles, CA.Irfan Khan Los Angeles Times Getty ImagesPeople at risk for monkeypox who have not received... + más

The First U.S. Data Show the Monkeypox Vaccine Is Effective | Time

HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC


CDC Has ‘Cautious Optimism’ Monkeypox Vax Is Slowing Spread

The Daily Beast USA Politics September 28, 2022

thumbnailPatients who have been vaccinated against the monkeypox virus were 14 times less likely to become infected than those who had not been vaccinated, according to initial data released by the Centers for Disease Control and Prevention on Wednesday, which public health officials say... + más

HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC

Los Angeles health officials are investigating the death of a person who had monkeypox | CNBC


Atea Pharma Says FDA Grants Fast Track Designation To AT-752 For Treatment Of Dengue

RTTNews USA Health September 26, 2022

thumbnailBiopharmaceutical company Atea Pharmaceuticals, Inc. () announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to AT-752, a novel, orally administered, direct-acting antiviral for the treatment of dengue virus infection.AT-752, a... + más

ALS drug wins FDA approval despite questionable data | ABC News

Council Post: How Social Media Analytics Is Transforming Pharma Decision Making | Forbes



About iurex | Privacy Policy | Disclaimer |